APCR
0.004
300%
IMC
0.039
-40%
MEU
0.12
71.4%
JNS
0.058
-38.9%
IFG
0.017
70%
TMB
0.049
-34.7%
VRC
0.01
66.7%
MIO
0.02
-33.3%
ALV
0.085
63.5%
PET
0.014
-30%
CTN
0.003
50%
CRS
0.091
-27.2%
IMM
0.375
47.1%
DTM
0.035
-27.1%
PER
0.01
42.9%
BAP
1.76
-25.1%
AUA
0.04
37.9%
NES
0.006
-25%
STV
0.011
37.5%
A11
0.155
-24.4%
ELS
2.67
35.5%
WNX
0.125
-24.2%
AGY
0.095
33.8%
AM5
0.007
-22.2%
ALY
0.012
33.3%
KLV
0.007
-22.2%
CHM
0.004
33.3%
NFL
0.11
-21.4%
RHY
0.105
32.9%
MNB
0.023
-20.7%
AR9
0.13
32.7%
CKA
0.054
-20.6%
ASL
2.43
31.4%
HVY
0.5
-20%
X2M
0.013
30%
TYX
0.004
-20%
LRM
0.031
29.2%
LKY
0.205
-19.6%
SPD
1.565
28.8%
SUM
0.033
-19.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CMP FDA clearance

Compumedics (ASX:CMP) announces the US FDA has cleared the Somfit device to be marketed in the USA. This marks the achievement of another significant strategic milestone for the Somfit technology platform in one of the world’s largest sleep markets https://www.compumedics.com.au/en/asx-announcements/somfit-update2-2/ #shorts